Surveillance of Patients at Increased Risk of Colon Cancer: Inflammatory Bowel Disease and Other Conditions

Gastroenterology Clinics of North America

Volumn 37, Issue 1, 2008, Pages 191-213

  Konda, Amulya ^a   Duffy, Michael C ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 ACETYLSALICYLIC ACID; FOLIC ACID; MESALAZINE; SALAZOSULFAPYRIDINE; SALICYLIC ACID DERIVATIVE; UNCLASSIFIED DRUG; URSODEOXYCHOLIC ACID;

ACROMEGALY; ADENOMATOUS POLYP; ANASTOMOSIS; BACTEREMIA; CANCER EPIDEMIOLOGY; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CHROMOENDOSCOPY; COLON CANCER; COLON RESECTION; COLONOSCOPY; DYSPLASIA; ENDOSCOPY; ENTERITIS; FAMILY HISTORY; FOLLOW UP; GASTROINTESTINAL TUMOR; HUMAN; PATHOGENESIS; POLYPECTOMY; PRACTICE GUIDELINE; PRIMARY PREVENTION; RECTUM HEMORRHAGE; REVIEW; RISK FACTOR; SECONDARY PREVENTION; STREPTOCOCCUS BOVIS; ULCERATIVE COLITIS; URETEROSIGMOIDOSTOMY; URINARY TRACT OBSTRUCTION;

COLORECTAL NEOPLASMS; HUMANS; INFLAMMATORY BOWEL DISEASES; MASS SCREENING; MORBIDITY; POPULATION SURVEILLANCE; RISK FACTORS;

EID: 39649096065     PISSN: 08898553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gtc.2007.12.013     Document Type: Review

References (157)

1. Bernstein C.N., Blanchard J.F., Kliewer E., et al. Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer 91 (2001) 854-862
2. Eaden J.A., Abrams K.R., and Mayberry J.F. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 48 (2001) 526-535
3. Pinczowski D., Ekbom A., Baron J., et al. Risk factors for colorectal cancer in patients with ulcerative colitis: a case-control study. Gastroenterology 107 (1994) 117-120
4. Winther K.V., Jess T., Langholz E., et al. Long term risk of cancer in ulcerative colitis: a population-based cohort study from Copenhagen county. Clin Gastroenterol Hepatol 2 (2004) 1088-1095
5. Jess T., Loftus E.V., Valeyos F.S., et al. Risk of intestinal cancer in inflammatory bowel disease: a population-based study from Olmsted County, Minnesota. Gastroenterology 130 (2006) 1039-1046
6. Eaden J.A., and Mayberry J.F. Colorectal cancer complicating ulcerative colitis: a review. Am J Gastroenterol 95 (2000) 2710-2719
7. Gyde S., Rrior P., Dew N.J., et al. Mortality in ulcerative colitis. Gastroenterology 83 (1982) 36-43
8. Friedman S., Rubin P.H., Bodian C., et al. Screening and surveillance colonoscopy in chronic Crohn's colitis. Gastroenterology 120 (2001) 820-826
9. Gillen C.D., Walmsley R.S., Prior P., et al. Ulcerative colitis and Crohn's disease: a comparison of the colorectal cancer risk in extensive colitis. Gut 35 (1994) 1590-1592
10. Choi P.M., and Zelig M.P. Similarity of colorectal cancer in Crohn's disease and ulcerative colitis: implications for carcinogenesis and prevention. Gut 35 (1994) 950-954
11. Clevers H. At the crossroads of inflammation and cancer. Cell 118 (2004) 671-674
12. Itzkowitz S.H., and Xio X. Inflammation and cancer IV: colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol 287 (2004) G7-G17
13. Vogelstein B., Fearon E.R., Hamilton S.R., et al. Genetic alterations during colorectal-tumor development. N Engl J Med 19 (1988) 525-532
14. Fearon E.R., and Vogelstein B. A genetic model for colorectal tumorignesis. Cell 61 (1990) 759-767
15. Brentnall T.A. Molecular underpinnings of cancer in ulcerative colitis. Curr Opin Gastroenterol 19 (2003) 64-68
16. Valeyos F.S., Loftus E.V., Jess T., et al. Predictive and protective factors associated with colorectal cancer in ulcerative colitis: a case-control study. Gastroenterology 130 (2006) 1941-1949
17. Rutter M., Saunders B., Wilkinson K., et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 126 (2004) 451-459
18. Broome U., Lofberg R., Veress B., et al. Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential. Hepatology 22 (1995) 1404-1408
19. Broome U., and Bergquist A. Primary sclerosing cholangitis, inflammatory bowel disease and colon cancer. Semin Liver Dis 26 (2006) 31-41
20. Brentnall T.A., Haggitt R.C., Rabinovitch P.S., et al. Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 110 (1996) 331-338
21. Kornfeld D., Eckom A., and Ihre T. Is there an excess risk for colorectal cancer in patients with ulcerative colitis and primary sclerosing cholangitis? A population based study. Gut 41 (1997) 522-525
22. Soetikno R.M., Lin O.S., Heidenreich P.A., et al. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis. Gastrointest Endosc 56 (2002) 48-54
23. Naggengast F., Grubben M., and van Munster I. Role of bile acids in colorectal carcinogenesis. Eur J Cancer 31 (1995) 1067-1070
24. Hueschen U.A., Hinz U., Allemeyer E.H., et al. Backwash ileitis is strongly associated with colorectal carcinoma in ulcerative colitis. Gastroenterology 120 (2001) 841-847
25. Greenstein A.J., Slater G., Heimann T.M., et al. A comparison of multiple synchronous colorectal cancer in ulcerative colitis, familial polyposis coli and de novo cancer. Ann Surg 203 (1986) 123-128
26. Harpaz N., and Tlbot I.C. Colorectal cancer in idiopathic inflammatory bowel disease. Semin Diagn Pathol 13 (1996) 339-357
27. Delauoit T., Limburg P.J., Goldberg R.M., et al. Colorectal cancer prognosis among patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 4 (2006) 335-342
28. Lashner B.A., Kane S.V., and Hanauer S.B. Colon cancer surveillance in chronic ulcerative colitis: historical cohort study. Am J Gastroenterol 85 (1990) 1083-1087
29. Choi P.M., Nugent F.W., Schoetz D.J., et al. Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis. Gastroenterology 105 (1993) 418-424
30. Karlen P., Kornfeld D., Brostrom O., et al. Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study. Gut 42 (1998) 711-714
31. Rutter M.D., Saunders B.P., Wilkinson K.W., et al. Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. Gastroenterology 130 (2006) 1030-1038
32. Collins P.D., Mpofu C., Watson A.J., et al. Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease. Cochrane Database Syst Rev 4 2 (2006) CD000279
33. Itzkowitz S.H., and Present D.H. Consensus conference: colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm Bowel Dis 11 (2005) 314-321
34. Odze R.D. Pathology of dysplasia and cancer in inflammatory bowel disease. Gastroenterol Clin North Am 35 (2006) 533-552
35. Dixon M.F., Brown L.J., Gilmour H.M., et al. Observer variation in the assessment of dysplasia in ulcerative colitis. Histopathology 13 (1988) 385-397
36. Rubin D.T., and Turner J.R. Surveillance of dysplasia in inflammatory bowel disease: the gastroenterologist-pathologist partnership. Clin Gastroenterol Hepatol 4 (2006) 1309-1313
37. Bernstein C.N., Shanahan F., and Weinstein W.M. Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis?. Lancet 353 (1994) 71-74
38. Torres C., Antonioli D., and Odze R.D. Polypoid dysplasia and adenomas in inflammatory bowel disease. A clinical, endoscopic and pathological study of 89 polyps in 59 patients. Am J Surg Pathol 22 (1998) 275-284
39. Ridell R.H., Goldman H., Ransohoff D.F., et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol 14 (1983) 931-968
40. Bernstein C.N. The color of dysplasia in ulcerative colitis. Gastroenterology 124 (2003) 1135-1149
41. Ullman T., Croog V., Harpaz N., et al. Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis. Gastroenterology 125 (2003) 1311-1319
42. Ullman T.A., Loftus E.V., Kakar S., et al. The fate of low grade dysplasia in ulcerative colitis. Am J Gastroenterol 97 (2002) 922-927
43. Befrits R., Ljung T., Jaramillo E., et al. Low-grade dysplasia in extensive, long-standing inflammatory bowel disease: a follow up study. Dis Colon Rectum 45 (2002) 615-620
44. Lim C.H., Dixon M.F., Vail A., et al. Ten year follow up of ulcerative colitis patients with and without low grade dysplasia. Gut 52 (2003) 1127-1132
45. Ullman T.A. Low-grade colorectal dysplasia and the need for colectomy. Gastroenterology & Hepatology 2 (2006) 868-870
46. Thomas T., Abrams K.A., Robinson R.J., et al. Meta-analysis: cancer risk of low-grade dysplasia in chronic ulcerative colitis. Aliment Pharmacol Ther 25 (2007) 657-668
47. D′Haens G. Dysplasia and cancer in ulcerative colitis: too many questions, too few answers. Digestion 73 (2006) 9-10
48. Bernstein C.N. Natural history and management of flat and polypoid dysplasia in inflammatory bowel disease. Gastroenterol Clin North Am 35 (2006) 573-579
49. Itzkowitz S.H., and Harpaz N. Diagnosis and management of dysplasia in patients with inflammatory bowel diseases. Gastroenterology 126 (2004) 1634-1648
50. Taylor B.A., Pemberton J.H., Carpenter H.A., et al. Dysplasia in chronic ulcerative colitis: implications for colonoscopic surveillance. Dis Colon Rectum 35 (1992) 950-956
51. Rubin P.H., Friedman S., Harpaz N., et al. Colonoscopic polypectomy in chronic colitis: conservative management after endoscopic resection of dysplastic polyps. Gastroenterology 117 (1999) 1295-1300
52. Engelsgjerd M., Farraye F.A., and Odze R.D. Polypectomy may be adequate treatment for adenoma-like dysplastic lesions in chronic ulcerative colitis. Gastroenterology 117 (1999) 1288-1294
53. Odze R.D., Farraye F.A., Hecht J.L., et al. Long-term follow-up after polypectomy treatment for adenoma-like dysplastic lesions in ulcerative colitis. Clin Gastroenterol Hepatol 2 (2004) 534-541
54. Bernstein C.N. ALMs versus DALMs in ulcerative colitis: polypectomy or colectomy?. Gastroenterology 117 (1999) 1488-1491
55. Marion J.F. Polypectomy versus proctocolectomy for adenoma patients with long-standing ulcerative colitis. Inflamm Bowel Dis 12 (2006) 914-915
56. American Society for Gastrointestinal Endoscopy. The role of colonoscopy in the management of patients with inflammatory bowel disease. Gastrointest Endosc 48 (1998) 689-690
57. Winawer S., Fletcher R., Rex D., et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale-update based on new evidence. Gastroenterology 124 (2003) 544-560
58. Eaden J.A., and Mayberry J.F. Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease. Gut 51 Suppl V (2002) v10-v12
59. Cohen J.L., Strong S.A., Hyman N.H., et al. Practice parameters for the surgical treatment of ulcerative colitis. Dis Colon Rectum 48 (2005) 1997-2009
60. Kornbluth A., and Sachar D.B. Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 99 (2004) 1371-1385
61. Connell W.R., Lennard-Jones J.E., William C.B., et al. Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. Gastroenterology 107 (1994) 934-944
62. Bernstein C.N., and Weinstein W.M. Physician's perceptions of dysplasia and approaches to surveillance colonoscopy in UC. Am J Gastroenterol 90 (1995) 2106-2114
63. Eaden J.A., Ward B.A., and Mayberry J.F. How gastroenterologists screen for colonic cancer in ulcerative colitis: an analysis of performance. Gastrointest Endosc 51 (2000) 123-128
64. Rodriguez S.A., Collins J.M., Knigge K.L., et al. Surveillance and management of dysplasia in ulcerative colitis. Gastrointest Endosc 65 (2007) 432-439
65. Hurlstone D.P., Sanders D.S., Lobo A.J., et al. Indigo carmine-assisted high-magnification chromoscopic endoscopy for the detection and characterization of intraepithelial neoplasia in UC: a prospective evaluation. Endoscopy 37 (2005) 1186-1192
66. Rutter M.D., Saunders B.P., Schofield G., et al. Pancolonic indigo carmine dye spraying for detection of dysplasia in ulcerative colitis. Gut 53 (2004) 256-260
67. Kiesslich R., and Neurath M.F. Chromoendoscopy and other novel techniques. Gastroenterol Clin North Am 35 (2006) 605-619
68. Thorlacius H., and Toth E. Role of chromoendoscopy in colon cancer surveillance in inflammatory bowel disease. Inflamm Bowel Dis 13 (2007) 911-917
69. Rutter M., Bernstein C., Matsumoto T., et al. Endoscopic appearance of dysplasia in ulcerative colitis and the role of staining. Endoscopy 36 (2004) 1109-1114
70. Kiesslich R., Fritsch J., Holtmann M., et al. Methylene blue-aided chromoendoscopy and colon cancer in ulcerative colitis. Gastroenterology 124 (2003) 880-888
71. Hurlstone D.P., Sanders D.S., McAlindon M.E., et al. High-magnification chromoscopic colonoscopy in ulcerative colitis: a valid tool for in vivo optical biopsy and assessment of disease extent. Endoscopy 38 (2006) 1213-1217
72. Kato S., Fu K.I., Sano Y., et al. Magnifying colonoscopy as a non-biopsy technique for differential diagnosis of non-neoplastic and neoplastic lesions. World J Gastroenterol 12 (2006) 1416-1420
73. Kiesslich R., Goetz M., Lammersdorf K., et al. Chromoscopy-guided endomicroscopy increases the diagnostic yield of intraepithelial neoplasia in ulcerative colitis. Gastroenterology 132 (2007) 874-882
74. Eaden J., Abrams K., Ekbom A., et al. Colorectal cancer prevention in ulcerative colitis: a case-control study. Aliment Pharmacol Ther 14 (2000) 145-153
75. van Staa T.P., Card T., Logan R.F., et al. 5-aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study. Gut 54 (2005) 1573-1578
76. Bernstein C.N., Blanchard J.F., Metge C., et al. Does the use of 5-aminosalicylates in inflammatory bowel disease prevent the development of colorectal cancer?. Am J Gastroenterol 98 (2003) 2784-2788
77. Terdiman J.P., Steibuch M., Blumentals W.A., et al. 5-aminosalicylic acid therapy and the risk of colorectal cancer among patients with inflammatory bowel disease. Inflamm Bowel Dis 13 (2007) 367-371
78. Valeyos F.S., Terdiman J.P., and Walsh J.M. Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: a systematic review and metaanalysis of observational studies. Am J Gastroenterol 100 (2005) 1345-1353
79. Bernstein C.N., Eaden J., Steinhart A.H., et al. Cancer prevention in inflammatory bowel disease and the chemoprophylactic potential of 5-aminosalicylic acid. Inflamm Bowel Dis 8 (2002) 356-361
80. Eaden J. Review article: the data supporting a role for salicylates in chemoprevention of colorectal cancer in patients with inflammatory bowel disease. Aliment Pharmacol Ther 18 Suppl 2 (2003) 15-21
81. Rubin D.T., and Lashner B.A. Will a 5-ASA a day keep the cancer (and dysplasia) away?. Am J Gastroenterol 100 (2005) 1354-1356
82. Tung B.Y., Edmond M.J., Haggitt R.C., et al. Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Ann Intern Med 134 (2001) 89-95
83. Pardi D.S., Loftus E.V., Kremers W.K., et al. Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis. Gastroenterology 124 (2003) 889-893
84. Giovannucci E., Stampfer M.J., Colditz G.A., et al. Folate, methionine and alcohol intake and risk of colorectal adenoma. J Natl Cancer Inst 85 (1993) 875-884
85. Lashner B.A., Heidenreich P.A., Su G.L., et al. Effect of folate supplementation on the incidence of dysplasia and cancer in chronic ulcerative colitis. Gastroenterology 97 (1989) 255-259
86. Lashner B.A., Provencher K.S., Seidner D.L., et al. The effect of folic acid supplementation on the risk for cancer or dysplasia in ulcerative colitis. Gastroenterology 112 (1997) 29-32
87. Langevin J.M., and Nivatvongs S. The true incidence of synchronous cancer of the large bowel: a prospective study. Am J Surg 147 (1984) 330-333
88. Passman M.A., Pommier R.F., and Vetto J.T. Synchronous colon primaries have the same prognosis as solitary colon cancers. Dis Colon Rectum 39 (1996) 329-334
89. Green R.J., Metlay J.P., Propert K., et al. Surveillance for second primary colorectal cancer after neo-adjuvant chemotherapy: an analysis of intergroup 0089. Ann Intern Med 136 (2002) 261-269
90. Barillari P., Ramacciato G., Manetti G., et al. Effectiveness of early detection of intraluminal recurrences on prognosis and survival of patients treated for cure. Dis Colon Rectum 38 (1996) 388-393
91. Juhl G., Larsin G.M., Mullins R., et al. Six-year results of annual colonoscopy after resection of colorectal cancer. World J Surg 14 (1990) 255-260
92. Jeffery G.M., Hickey B.E., and Hider P. Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane database Sys Rev (2002) CD002200
93. Schoemaker D., Black R., Giles L., et al. Yearly colonoscopy, liver CT and chest radiography do not influence 5-year survival of colorectal cancer patients. Gastroenterology 114 (1998) 7-14
94. Renehan A.G., Egger M., Saunders M.P., et al. Impact on the survival of intensive followup after curative resection for colorectal cancer: systematic review and meta-analysis of randomized trials. Br Med J 324 (2002) 813
95. Kapiteijn E., Marijnen C.A., Nagtegaal I.D., et al. Dutch colorectal cancer group. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345 (2001) 638-646
96. Rex D.K., Kahi C.J., Levin B., et al. Guideline for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and the US Multi-Society task force on colorectal cancer. Gastroenterology 130 (2006) 1865-1871
97. Atkin W.S., Morson B.C., and Cuzick J. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med 326 (1992) 658-662
98. Yang G., Zheng W., Sun Q.R., et al. Pathologic features of initial adenomas as predictors for metachronous adenomas of the rectum. J Natl Cancer Inst 90 (1998) 1661-1665
99. Loeve F., Van Ballegooijen M., Boer R., et al. Colorectal cancer risk in adenoma patients. A nation wide study. Int J Cancer 111 (2004) 147-151
100. Lieberman D.A., and Weiss D.G. Five year surveillance of patients with adenomas or colorectal cancer at screening colonoscopy. results from the VA Co-operative Study #380. [abstract]. Gastroenterology 126 (2004) A22
101. Robertson D.J., Greenberg E.R., Beach M., et al. Colorectal cancer in patients under close colonoscopic surveillance. Gastroenterology 129 (2005) 34-41
102. Bonithon-Kopp C., Piard F., Fenger C., et al. Colorectal adenomas characteristics as predictors of recurrence. Dis Colon Rectum 47 (2004) 323-333
103. Martinez M.E., Sampliner R., Marshall J.R., et al. Adenoma characteristics as risk factors for recurrence of advanced adenomas. Gastroenterology 120 (2001) 1077-1083
104. Noshirwani K., Van Stolk R.U., Rybicki L.A., et al. Adenoma size and number are predictive of adenoma recurrence: implications for surveillance colonoscopy. Gastrointest Endosc 51 (2000) 433-437
105. Winawer S.J., Zauber A.G., Fletcher R.H., et al. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on colorectal cancer and the American Cancer Society. CA Cancer J Clin 56 (2006) 143-159
106. Fuchs C.S., Giovannucci E.L., Colditz G.A., et al. A prospective study of family history and risk of colorectal cancer. N Engl J Med 331 (1994) 1669-1674
107. Winawer S.J., Zauber A.G., Gerdes H., et al. Risk of colorectal cancer in families of patients with adenomatous polyps. N Engl J Med 334 (1996) 82-87
108. Johns L.E., and Houlston R.S. A systematic review and meta-analysis of familial colorectal cancer risk. Am J Gastroenterol 96 (2001) 2992-3003
109. Butterworth A.S., Higgins J.P., and Pharoah P. Relative and absolute risk of colorectal cancer for individuals with a family history: a meta-analysis. Eur J Cancer 42 (2006) 216-227
110. Urbanski S.J., Kossakowska A.E., Marcon N., et al. Mixed hyperplastic adenomatous polyps: an underdiagnosed entity; report of a case of adenocarcinoma arising within mixed hyperplastic polyp. Am J Surg Pathol 8 (1984) 551-556
111. Longacre T.A., and Fenoglio-Preiser C.M. Mixed hyperplastic adenomatous polyps/serrated adenomas. A distinct form of colorectal neoplasia. Am J Surg Pathol 14 (1990) 524-537
112. Torlakovic E., and Snover D.C. Serrated adenomatous polyposis in humans. Gastroenterology 110 (1996) 748-755
113. Goldstein N.S., Bhanot P., Odish E., et al. Hyperplastic-like colon polyps that preceded microsatellite-unstable adenocarcinomas. Am J Clin Pathol 119 (2003) 778-796
114. Mäkinen M.J., George S.M., Jernvall P., et al. Colorectal carcinoma associated with serrated adenoma-prevalence, histological features, and prognosis. J Pathol 193 (2001) 286-294
115. Jass J.R. Serrated route to colorectal cancer: back street or super highway?. J Pathol 193 (2001) 283-285
116. Hawkins N.J., and Ward R.L. Sporadic colorectal cancers with microsatellite instability and their possible origin hyperplastic polyps and serrated adenomas. J Natl Cancer Inst 93 (2001) 1307-1313
117. Wynter C.V.A., Walsh M.D., Higuchi T., et al. Methylation patterns define two types of hyperplastic polyp associated with colorectal cancer. Gut 53 (2004) 573-580
118. Spring K.J., Zhao Z.Z., Karamatic R., et al. High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy. Gastroenterology 131 (2006) 1400-1407
119. Kambara T., Simms L.A., Whitehall V.L.J., et al. BRAF mutation and CpG island methylation: an alternative pathway to colorectal cancer. Gut 53 (2004) 1137-1144
120. Snover D.C., Jass J.R., Preiser C.F., et al. Serrated polyps of the large intestine. A morphologic and molecular review of an evolving concept. Am J Clin Pathol 124 (2005) 380-391
121. Torlakovic E., Skovland E., Snover D.C., et al. Morphological reappraisal of serrated colorectal polyps. Am J Surg Pathol 27 (2003) 65-81
122. Rashid A., Houlihan P.S., Booker S., et al. Phenotypic and molecular characteristics of hyperplastic polyposis. Gastroenterology 119 (2000) 323-332
123. Leggett B.A., Devereaux B., Biden K., et al. Hyperplastic polyposis: association with colorectal cancer. Am J Surg Pathol 25 (2001) 65-81
124. Renaut A.J., Douglas P.R., and Newstead G.L. Hyperplastic polyposis of the colon and rectum. Colorectal Dis 4 (2002) 213-215
125. Higuchi T., and Jass J.R. My approach to serrated polyps of the colorectum. J Clin Pathol 57 (2004) 682-686
126. Ezzat S., Strom C., and Melmed S. Colon polyps in acromegaly. Ann Intern Med 114 (1991) 754-755
127. Swerdlow A., Higgins C., Adlard P., et al. Risk of cancer in patients treated with human pituitary growth hormone in the UK, 1959-85: a cohort study. Lancet 360 (2002) 273-277
128. Jenkins P.J., Fairclough O.D., Richards T., et al. Acromegaly, colon polyps and carcinoma. Clin Endocrinol 47 (1997) 17-22
129. Ladas S.D., Thalassinos N.C., Ioannides G., et al. Does acromegaly really predispose to an increased prevalence of gastrointestinal tumors?. Clin Endocrinol 41 (1994) 597-601
130. Terzolo M., Reimondo G., Gasperi M., et al. Colonoscopic screening and follow-up in patients with acromegaly: a multicenter study in Italy. J Clin Endocrinol Metab 90 (2005) 84-90
131. Renehan A.G., Bhaskar P., Painter J.E., et al. The prevalence and characteristics of colorectal neoplasia in acromegaly. J Clin Endocrinol Metab 85 (2000) 3417-3424
132. Cats A., Dullaart R.P., Kleibeuker J.H., et al. Increased epithelial cell proliferation in the colon of patients with acromegaly. Cancer Res 56 (1996) 523-526
133. Remacle-Bonnet M.M., Garrouste F.L., Heller S., et al. Insulin-like growth factor-I protects colon cancer cells from death factor-induced apoptosis by potentiating tumor necrosis factor α-induced mitogen-activated protein kinase and nuclear factor κB signaling pathways. Cancer Res 60 (2000) 2007-2017
134. Jenkins P.J., Frajese V., Jones A.M., et al. Insulin-like growth factor I and the development of colorectal neoplasia in acromegaly. J Clin Endocrinol Metab 85 (2000) 3218-3221
135. Bogazzi F., Cosci C., Sardella C., et al. Identification of acromegalic patients at risk of developing colonic adenomas. J Clin Endocrinol Metab 91 (2006) 1351-1356
136. Hammer E. Cancer du colon sigmoide dix ans après implantation aux ureters d'une versie extrophies. J Urol 28 (1929) 260-264
137. Stewart M., Macrae F.A., and Williams C.B. Neoplasia and ureterosigmoidostomy: a colonoscopic survey. Br J Surg 69 (1982) 414-416
138. Tricker A.R., Kalble T., and Preussmann R. Increased urinary nitrosoamine excretion in patients with urinary diversions. Carcinogenesis 10 (1989) 2379-2382
139. Crissey M.M., Steele G.D., and Gittes R.F. Rat model for carcinogenesis in ureterosigmoidostomy. Science 207 (1980) 1079-1080
140. Parsons C.D., Thomas M., and Garrett R. Colonic adenocarcinoma: a delayed complication of ureterosigmoidostomy. J Urol 118 (1977) 31-34
141. Sooriyaarachchi G., Johnson R.O., and Carbone P. Neoplasms of the large bowel following ureterosigmoidostomy. Arch Surg 112 (1977) 1174-1177
142. Strachan J.R., and Woodhouse C.R. Malignancy following ureterosigmoidostomy in patients with extrophy. Br J Surg 78 (1991) 1216-1218
143. Schipper H., and Decter A. Carcinoma of the colon arising at ureteral implant sites despite early external diversion. Cancer 47 (1981) 2062-2065
144. Azimuddin K., Rosen L., Khubchandani I.T., et al. Neoplasia after ureterosigmoidostomy. Dis Colon Rectum 42 (1999) 1632-1638
145. Urdaneta H., Duffell D., and Creevey C.D. Development of primary carcinoma of the colon following ureterosigmoidostomy. Ann Surg 164 (1982) 503-513
146. Brekkan E., Colleen S., and Myrvoid H. Colonic neoplasia: a late complication of ureterosigmoidostomy. Scand J Urol Nephrol 6 (1972) 197-202
147. Woodhouse C.R.J. Guidelines for monitoring of patients with ureterosigmoidostomy. Gut 51 Suppl V (2002) v15-v16
148. Keush G.T. Opportunistic infections in colon carcinoma. Am J Clin Nutr 27 (1974) 1481-1485
149. McCoy W.C., and Mason J.M. Enterococcal endocarditis associated with carcinoma of the sigmoid: report of a case. J Med Assoc State Ala 21 (1951) 162-166
150. Burns C.A., McCaughey R., and Lauter C.B. The association of Streptococcus bovis fecal carriage and colon neoplasia: possible relationship with polyps and their premalignant potential. Am J Gastroenterol 80 (1985) 42-46
151. Leport C., Bure A., Leport J., et al. Incidence of colonic lesions in Streptococcus bovis and enterococcal endocarditis. Lancet 1 (1987) 748
152. Klein R.S., Recco R.A., Catalano M.T., et al. Association of Streptococcus bovis with carcinoma of the colon. N Engl J Med 287 (1977) 800-802
153. Potter M.A., Cunliffe N.A., Smith M., et al. A prospective controlled study of the association of Streptococcus bovis with colorectal carcinoma. J Clin Pathol 51 (1998) 473-474
154. Murray H.W., and Roberts R.B. Streptococcus bacteremia and underlying gastrointestinal disease. Arch Intern Med 138 (1978) 1097-1099
155. Honberg O.Z., and Gutschick E. Streptococcus bovis bacteremia and its association with alimentary-tract neoplasm. Lancet 1 8525 (1987) 163-164
156. Wanke C.A., and Bistrian B. Recombinant human tumor necrosis factor and recombinant murine interleukin-1 alter the binding of Escherichia coli to intestine, mucine glycoprotein, and the HT29-C1 intestinal cell line. Nutrition 13 (1997) 959-964
157. Ellmericch S., Schöller M., Duranton B., et al. Promotion of intestinal carcinogenesis by Streptococcus bovis. Carcinogenesis 21 (2000) 753-756